See more : JW Pharmaceutical Corporation (001065.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Morn Sun Feed Mill Corp. (1240.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Morn Sun Feed Mill Corp., a leading company in the None industry within the None sector.
You may be interested
- Seven Hills Realty Trust (RMRM) Income Statement Analysis – Financial Results
- CodeLab Capital AS (CODE.OL) Income Statement Analysis – Financial Results
- NKGen Biotech, Inc. Common Stock (NKGN) Income Statement Analysis – Financial Results
- Norion Bank AB (NORION.ST) Income Statement Analysis – Financial Results
- Chesapeake Utilities Corporation (CPK) Income Statement Analysis – Financial Results
Morn Sun Feed Mill Corp. (1240.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.91B | 3.37B | 3.00B | 2.28B | 1.82B |
| Cost of Revenue | 2.62B | 3.12B | 2.75B | 2.01B | 1.56B |
| Gross Profit | 294.55M | 251.94M | 254.43M | 266.88M | 257.37M |
| Gross Profit Ratio | 10.12% | 7.47% | 8.48% | 11.72% | 14.15% |
| Research & Development | 4.07M | 4.85M | 5.74M | 18.70M | 14.30M |
| General & Administrative | 78.46M | 61.20M | 72.31M | 84.17M | 0.00 |
| Selling & Marketing | 139.86M | 182.12M | 158.64M | 109.77M | 0.00 |
| SG&A | 218.32M | 243.32M | 230.94M | 193.95M | 147.94M |
| Other Expenses | -51.74M | 13.76M | 88.31M | 88.84M | 0.00 |
| Operating Expenses | 169.24M | 251.01M | 235.69M | 207.15M | 162.24M |
| Cost & Expenses | 2.78B | 3.37B | 2.98B | 2.22B | 1.72B |
| Interest Income | 1.18M | 139.00K | 126.00K | 194.00K | 52.00K |
| Interest Expense | 9.57M | 7.63M | 3.11M | 3.54M | 3.53M |
| Depreciation & Amortization | 40.41M | 39.96M | 33.79M | 19.06M | 13.50M |
| EBITDA | 222.47M | 41.44M | 177.64M | 209.52M | 129.98M |
| EBITDA Ratio | 7.64% | 1.31% | 5.83% | 9.00% | 7.15% |
| Operating Income | 180.66M | 4.13M | 141.01M | 185.87M | 95.13M |
| Operating Income Ratio | 6.21% | 0.12% | 4.70% | 8.16% | 5.23% |
| Total Other Income/Expenses | -8.17M | -10.28M | -270.00K | 1.05M | 1.79M |
| Income Before Tax | 172.50M | -6.15M | 140.74M | 186.93M | 112.95M |
| Income Before Tax Ratio | 5.93% | -0.18% | 4.69% | 8.21% | 6.21% |
| Income Tax Expense | 36.60M | 12.81M | 31.50M | 40.90M | 30.19M |
| Net Income | 162.31M | 5.59M | 131.17M | 155.49M | 136.41M |
| Net Income Ratio | 5.58% | 0.17% | 4.37% | 6.83% | 7.50% |
| EPS | 3.93 | 0.14 | 3.33 | 3.95 | 3.30 |
| EPS Diluted | 3.91 | 0.14 | 3.32 | 3.93 | 3.29 |
| Weighted Avg Shares Out | 41.34M | 39.37M | 39.37M | 39.37M | 41.34M |
| Weighted Avg Shares Out (Dil) | 41.47M | 39.41M | 39.51M | 39.55M | 41.49M |
No news found for: 1240.TWO
Source: https://incomestatements.info
Category: Stock Reports